Presentation by CEO Mark Engel Highlighting both Platform and Product Pipeline Advances DOVER, Del., Jan. 5, 2024 /PRNewswire/ -- Precisio Biotix today announced that it is presenting at both the...

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that...

Halia Therapeutics, a clinical-stage biopharmaceutical company, is pioneering a novel class of small molecule medications designed to combat inflammation. Today, the company announced that its...

Biotech Showcase coincides with the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco January 8-11, 2024 IRVINE, Calif., Jan. 2, 2024 /PRNewswire/ -- VESICA HEALTH, INC., a...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, R&D VP of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present...